当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:323.05亿  总市值:323.05亿
流通股本:28.04亿   总股本:28.04亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金20,017,362,283.1713,004,397,294.896,460,790,151.4727,266,900,172.11
  收到的税费返还437,089,373.63255,379,073.62135,732,651.36590,412,944.2
  收到其他与经营活动有关的现金259,273,351.77191,153,397.33158,096,619.85448,943,253.14
  经营活动现金流入小计20,713,725,008.5713,450,929,765.846,754,619,422.6828,306,256,369.45
  购买商品、接受劳务支付的现金13,161,667,283.299,083,489,211.255,141,844,989.2320,140,823,405.6
  支付给职工以及为职工支付的现金1,386,666,122.25904,015,836.36483,716,5621,968,598,894.6
  支付的各项税费838,239,192.44597,189,446.61273,103,809.51859,863,649.52
  支付其他与经营活动有关的现金615,992,412.25553,444,050.99402,686,991.25710,255,629.26
  经营活动现金流出小计16,002,565,010.2311,138,138,545.216,301,352,351.9923,679,541,578.98
  经营活动产生的现金流量净额4,711,159,998.342,312,791,220.63453,267,070.694,626,714,790.47
二、投资活动产生的现金流量:
  收回投资收到的现金24,295,712.5173,892,375.1423,752,887.87190,804,566.68
  取得投资收益收到的现金42,580,649.6116,498,9797,969,507.5951,309,310.71
  处置固定资产、无形资产和其他长期资产收回的现金净额2,152,974.231,245,921.83,707.83,487,009.2
  投资活动现金流入小计69,029,336.3591,637,275.9431,726,103.26245,600,886.59
  购建固定资产、无形资产和其他长期资产支付的现金1,523,816,613.121,087,107,997.28552,920,288.672,004,423,105.69
  投资支付的现金1,915,477,856.391,944,967,826.41,629,455,144881,089,058.61
  取得子公司及其他营业单位支付的现金200,613,641.06---
  支付其他与投资活动有关的现金3,803,296.412,859,048.14472,5009,047,530
  投资活动现金流出小计3,643,711,406.983,034,934,871.822,182,847,932.672,894,559,694.3
  投资活动产生的现金流量净额-3,574,682,070.63-2,943,297,595.88-2,151,121,829.41-2,648,958,807.71
三、筹资活动产生的现金流量:
  取得借款收到的现金4,197,857,434.782,874,965,205.641,459,109,699.946,297,183,657.37
  收到其他与筹资活动有关的现金546,103,814.09428,515,211.85165,062,467.78389,646,523.23
  筹资活动现金流入小计4,743,961,248.873,303,480,417.491,624,172,167.726,686,830,180.6
  偿还债务支付的现金3,928,170,000.012,629,070,0001,253,360,0006,411,943,930.69
  分配股利、利润或偿付利息支付的现金1,242,864,719.661,228,810,522.7612,265,180.311,789,239,618.91
  支付其他与筹资活动有关的现金614,073,851.66255,748,337.46182,309,929.841,223,698,914.69
  筹资活动现金流出小计5,785,108,571.334,113,628,860.221,447,935,110.159,424,882,464.29
  筹资活动产生的现金流量净额-1,041,147,322.46-810,148,442.73176,237,057.57-2,738,052,283.69
四、汇率变动对现金及现金等价物的影响25,528,099.831,539,177.2322,189,675.61111,541,460.34
五、现金及现金等价物净增加额120,858,705.05-1,409,115,640.75-1,499,428,025.54-648,754,840.59
  加:期初现金及现金等价物余额4,131,859,602.144,131,859,602.144,131,859,602.264,780,614,442.73
  期末现金及现金等价物余额4,252,718,307.192,722,743,961.392,632,431,576.724,131,859,602.14
补充资料:
  净利润-1,767,950,116.89-2,740,427,215.56
  资产减值准备-9,236,606.64-6,981,927.26
  固定资产和投资性房地产折旧-663,310,890.94-1,275,227,848.29
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-663,310,890.94-1,275,227,848.29
  无形资产摊销-20,437,708.39-45,749,650.73
  长期待摊费用摊销-18,080,269.41-36,976,072.81
  处置固定资产、无形资产和其他长期资产的损失--438,552.05--29,968.32
  固定资产报废损失-6,570,163.08-34,405,586.69
  公允价值变动损失--16,016,844.67--14,826,169.53
  财务费用--737,611.57--29,377,272.58
  投资损失--29,250,766.79--30,193,009.09
  递延所得税--20,007,640.1-15,127,342.15
  其中:递延所得税资产减少--19,972,579.93-14,034,060.21
    递延所得税负债增加--35,060.17-1,093,281.94
  存货的减少-208,943,971.2-202,965,494.39
  经营性应收项目的减少--3,689,852.79-306,096,165.23
  经营性应付项目的增加--313,556,197.56-37,357,071.5
  现金的期末余额-2,722,743,961.39-4,131,859,602.14
  减:现金的期初余额-4,131,859,602.14-4,780,614,442.73
  现金及现金等价物的净增加额--1,409,115,640.75--648,754,840.59
公告日期2025-10-302025-08-202025-04-222025-03-18
审计意见(境内)标准无保留意见
TOP↑